Promoting of Adherence to Antihypertensive Treatment through a Pharmaceutical Care Service Supported by Mobile Phones

DOI:  https://doi.org/10.12804/revistas.urosario.edu.co/revsalud/a.12127

Article Sidebar

PDF (Español (España)) HTML (Español (España)) XML (Español (España))

Published: May 31, 2024
Issue: Vol. 22 No. 2 (2024): Revista Ciencias de la Salud
Section Clinical or Experimental Research


Main Article Content

Authors

  Marina Mercedes Lezcano
Universidad Nacional de Asunción. Facultad de Ciencias Químicas. Docente
Gladys Beatriz Lugo
Universidad Nacional de Asunción. Facultad de Ciencias Químicas. Dirección de Investigaciones. Departamento de Farmacia. Docente Investigador
  Ana Aguilar Rabito
Universidad Nacional de Asunción. Facultad de Ciencias Químicas. Dirección de Investigaciones. Departamento de Nutricion. Docente Investigador
  Gladys Maidana
Facultad de Ciencias Químicas - UNA

Abstract

Introduction. High blood pressure continues to be a challenge for public health in Paraguay, the lack of adherence to treatment is a problem from the medical, economic and psychosocial point of view. The use of technology is a useful tool in monitoring patients and improving adherence to pharmacological treatment.


Objetive. To evaluate adherence to antihypertensive pharmacological treatment in patients with hypertension who attend a public health service, through a digital telephone tool.


Materials and methods. Quasi-experimental study carried out in patients older than 18 years of both sexes with arterial hypertension; in which pharmaceutical interventions were applied through technology and adherence to treatment was evaluated using the Morisky-Green questionnaire, along with complementary questions to find out the causes. The research protocol was approved by a Research Ethics Committee of the FCQ-UNA (714/2021).


Results. 60 patients participated. 68.3% (n=41) at the beginning showed adherence to treatment according to the Morisky-Green questionnaire, and 31.7% (n=19) did not comply with the indication, after the interventions a greater adherence to treatment, reaching 96.7% of adherents (p<0.00001), being causes of non-adherence to pharmacotherapy forgetfulness 28.3% (n=17), lack of availability of the medication in the hospital 20 % (n=12) and cost 10% (n=6).


Conclusion. The use of technology could become a tool for primary prevention in the population with risk factors, and the monitoring of patients with arterial hypertension.

Author Biography

Ana Aguilar Rabito, Universidad Nacional de Asunción. Facultad de Ciencias Químicas. Dirección de Investigaciones. Departamento de Nutricion. Docente Investigador

Docente de la Facultad de Ciencias Quimicas

How to Cite
Lezcano, M. M., Lugo, G. B., Aguilar Rabito, A., & Maidana, G. (2024). Promoting of Adherence to Antihypertensive Treatment through a Pharmaceutical Care Service Supported by Mobile Phones. Revista Ciencias De La Salud, 22(2), 1–16. https://doi.org/10.12804/revistas.urosario.edu.co/revsalud/a.12127
References

Ministerio de Salud Pública y Bienestar Social, OPS OP de la S. Primera Encuesta Nacional de Factores de Riesgo [Internet]. Disponible en: https://www.who.int/ncds/surveillance/steps/2011_STEPS_Paraguay_leaflet.pdf

Ortellado Maidana J, Ramírez A, González G, Olmedo Filizzola G, Ayala de Doll M, Sano M, et al. 2015 Paraguayan Consensus on Arterial Hypertension. Rev Virtual la Soc Paraguaya Med Interna. 2016;3(2):11-57.

Kumar V, Abbas AK, Fausto N, Aster JC. Robbins & Cotran pathologic basis of disease. 8.ª ed. Filadelfia: Saunders Elsevier; 2010.

Díaz Molina CM, Herrera Preval Y, Matéu López L. Adherencia al tratamiento antihipertensivo en pacientes del municipio San Miguel del PadrónInstituto de Farmacia y Alimentos. Rev Cuba Farm. 2014;48(4):588-97.

Burt VL, Whelton P, Roccella E, Brown C, Cutler JA, Higgins M, et al. Prevalence of hypertension in the US adult population: results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension. 1995;25(3):305-13.

Greenberg RN. Overview of patient compliance with medication dosing: a literature review. Clin Ther. 1984;6(5):592-9.

Flack JM, Novikov S V, Ferrario CM. Benefits of adherence to anti-hypertensive drug therapy. Eur Heart J. 1996;17:16-20.

Caro JJ, Salas M, Speckman JL, Raggio G, Jackson JD. Persistence with treatment for hypertension in actual practice. CMAJ. 1999;160(1):31-7.

Pagès-Puigdemont N, Valverde-Merino MI, FausDáder J. Adherencia terapéutica: factores modificadores y estrategias de mejora. ArsPharm. 2018;59(4):251-8.

Maidana GM, Lugo G, Vera Z, Acosta P, Morinigo M, Isasi D, et al. Factores que determinan la falta de adherencia de pacientes diabéticos a la terapia medicamentosa. Mem Inst Investig Cienc Salud. 2016;14(1):70-7.

Lugo G, Bittner MR, Chávez H, Pérez S. Implementación de un programa de atención farmacéutica en farmacias comunitarias para la detección de la hipertensión arterial y su seguimiento farmacoterapéutico. Lat Am J Pharm. 2007;26(4):590-5.

Maidana G, Lugo G, Vera Z, Pérez S, Mastroianni P. Evaluación de un programa de atención farmacéutica en pacientes con diabetes mellitus tipo 2. Pharm Care Esp. 2016;18(1):3-15.

González-Ruiz D, Getial-Mora D, Higidio-Miranda M, Hernández-Zambrano S. Efectividad de las tecnologías de la información y comunicación en la adherencia terapéutica de pacientes con hipertensión arterial y diabetes mellitus. Enferm Nefrol. 2020;23(1):22-32.

Díaz de León-Castañeda C. Salud electrónica (e-Salud): un marco conceptual de implementación en servicios de salud. Gac Med Mex. 2019;155(2). https://doi.org/10.24875/GMM.18003788

Morisky DE, Ang A, Krousel‐Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens. 2008;10(5):348-54.

Consejo de Organizaciones Internacionales de las Ciencias Médicas (CIOM). Pautas éticas internacionales para la investigación biomédica en seres humanos [internet]. 2002 [citado 2021 abr 20]. Disponible en: http://www.ub.edu/rceue/archivos/Pautas_Eticas_Internac.pdf

González Alfonso A, González Alfonso N, Vázquez González Y, González Alfonso L, Gómez Pacheco R. Importancia de la participación familiar en el control de la hipertensión arterial. Medicentro. 2004;8(2):1-7.

Aid Kunert J. Adherencia al tratamiento antihipertensivo en pacientes ambulatorios de un hospital urbano. Rev Virtual Soc Parag Med Int. 2015;2(2):43-51. https://doi.org/10.18004/rvspmi/2312-3893/2015.02(02)43-051

Durán B, Rivera B, Franco E. Apego al tratamiento farmacológico en pacientes con diagnóstico de diabetes mellitus tipo 2. Salud Pública Méx. 2001;43(3):233-6.

Ramírez C. Adherencia a la farmacoterapia en pacientes hipertensos ambulatorios que asisten al programa de control de hipertensión arterial en el Hospital Jorge Cristo Sahium, Norte de Santander (Colombia). Cienc Tecnol Salud Vis Ocul. 2014;12(2):27-35. https://doi.org/10.19052/sv.3291

Morales Ortega CB. Evaluación del uso de la tecnología para optimizar la adherencia a la medicación de pacientes hipertensivos crónicos que acuden a la Clínica Periférica INGAVI del Instituto de Previsión Social [tesis de grado]. San Lorenzo-Paraguay: Facultad de Ciencias Químicas-Universid; 2019.

Acevedo VD, Castaño Castrillón JJ, Giraldo JFM, Escobar V, Ernesto Felizzola G, Gómez ML, et al. Prevalencia de dislipidemias en pacientes hipertensos que asisten al hospital San Marcos, Chinchiná, Caldas, Colombia, 2014 [internet]. 2015. Disponible en: https://ridum.umanizales.edu.co/xmlui/handle/20.500.12746/2161

Fornos Pérez J, García Rodríguez G, Fernández Cordeiro M, González Añón D, Rodríguez N. Evaluación del conocimiento, el cumplimiento y la satisfacción del tratamiento en pacientes diabéticos en la oficina de farmacia. Av Diabetol. 2008;24(5):399-406.

Vivian E. Improving blood pressure control in a pharmacist-managed hypertension clinic. Pharmacother J Hum Pharmacol Drug Ther. 2002;22(12):1533-40. https://doi.org/10.1592/phco.22.17.1533.34127

Leon N, Surender R, Bobrow K, Muller J, Farmer A. Improving treatment adherence for blood pressure lowering via mobile phone SMS-messages in South Africa: a qualitative evaluation of the SMS-text Adherence SuppoRt (StAR) trial. BMC Fam Pract. 2015;16(1):1-10. https://doi.org/10.1186/s12875-015-0289-7

Bittner R. Pharmacy’s participation in medicare: diabetes self-management education. En: NACDS; 2001.

Rigby D. Collaboration between doctors and pharmacists in the community. Aust Prescr. 2010;33:191-3.

Cranor C, Christensen D. The Asheville Project: short-term outcomes of a community pharmacy diabetes care program. JAPHA. 2003;43(2):149-59.

Devine E, Hoang S, Fisk A, Wilson-Norton J, Lawless N, Louie C. Strategies to optimize medication use in the physician group practice: the role of the clinical pharmacist. J Am Pharm Assoc. 2009;49(2):181-91.

Snyder M, Zillich A, Primack B, Rice K, Somma Mcgivney M, Pringle J, et al. Exploring successful community pharmacist physician collaborative working relationships using mixed methods. Res Soc Adm Pharm. 2010;6(4):307-23.

Carter B, Ardery G, Dawson J, James P, Bergus G, Doucette W, et al. Physician and pharmacist collaboration to improve blood pressure control. Arch Intern Med. 2009;169:1996-2002. https://doi.org/10.1001/archinternmed.2009.358

Hackam D, Khan N, Hemmelgarn B, Rabkin S, Touyz R, Campbell N. Canadian Hypertension Education Program: The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy. Can J Cardiol. 2010;26(5):249-58.

Mclean D, Mcalister F, Johnson J, King K, Makowsky M, Jones C. A randomized trial of the effect of community pharmacist and nurse care on improving blood pressure management in patients with diabetes mellitus: Study of Cardiovascular Risk Intervention by Pharmacists-Hypertension (SCRIP-HTN). Arch Intern Med. 2008;168:2355-61.

Owens C, Baergen R, Cady P. Multistate survey of primary care physician and midlevel provider attitudes toward community pharmacists. J Am Pharm Assoc. 2009;49(9):538-43.

Query Statistics

Downloads

Download data is not yet available.
Publcation metrics

0




 

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Published articles are solely the authors’ responsibility and do not commit the Editorial Committee nor the Scientific Committee. The copyrights belong to the Revista Ciencias de la Salud, therefore, total or partial reproduction of the published material is forbidden, unless there is a previous authorization.